117 related articles for article (PubMed ID: 7859452)
1. Risk of cervical dysplasia in users of oral contraceptives, intrauterine devices or depot-medroxyprogesterone acetate. The New Zealand Contraception and Health Study Group.
Contraception; 1994 Nov; 50(5):431-41. PubMed ID: 7859452
[TBL] [Abstract][Full Text] [Related]
2. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
Colli E; Tong D; Penhallegon R; Parazzini F
Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866
[TBL] [Abstract][Full Text] [Related]
3. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
4. Hospitalizations among black women using contraceptives.
Higgins JE; Wilkens LR; Chi IC; Hatcher RA
Am J Obstet Gynecol; 1985 Oct; 153(3):280-7. PubMed ID: 2931987
[TBL] [Abstract][Full Text] [Related]
5. New Zealand contraception and health study: design and preliminary report. New Zealand Contraception and Health Study Group.
N Z Med J; 1986 Apr; 99(800):283-6. PubMed ID: 3458082
[TBL] [Abstract][Full Text] [Related]
6. History of long-term use of depot-medroxyprogesterone acetate in patients with cervical dysplasia; case-control analysis nested in a cohort study. The New Zealand Contraception and Health Study Group.
Contraception; 1994 Nov; 50(5):443-9. PubMed ID: 7859453
[TBL] [Abstract][Full Text] [Related]
7. Differences in cervical cytologic and histologic findings between women using depot-medroxyprogesterone acetate and oral contraceptives.
Clark MK; Stockdale CK; Railsback L; Nichols S
J Low Genit Tract Dis; 2011 Jul; 15(3):219-23. PubMed ID: 21716050
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ.
Ory H; Naib Z; Conger SB; Hatcher RA; Tyler CW
Am J Obstet Gynecol; 1976 Mar; 124(6):573-7. PubMed ID: 1258912
[TBL] [Abstract][Full Text] [Related]
9. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
10. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
McFarlane-Anderson N; Bazuaye PE; Jackson MD; Smikle M; Fletcher HM
BMC Womens Health; 2008 May; 8():9. PubMed ID: 18513406
[TBL] [Abstract][Full Text] [Related]
11. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
12. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
13. An attempt to estimate the incidence of cervical dysplasia in a group of New Zealand women using contraception. The New Zealand Contraception and Health Study Group.
Epidemiology; 1995 Mar; 6(2):121-6. PubMed ID: 7742396
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of endometriosis in women attending family planning clinics.
Vessey MP; Villard-Mackintosh L; Painter R
BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study.
Loopik DL; IntHout J; Melchers WJG; Massuger LFAG; Bekkers RLM; Siebers AG
Eur J Cancer; 2020 Jan; 124():102-109. PubMed ID: 31760309
[TBL] [Abstract][Full Text] [Related]
16. Effects of contraceptive pills and intrauterine devices on urinary bladder.
Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
[TBL] [Abstract][Full Text] [Related]
17. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
Vercellini P; De Giorgi O; Oldani S; Cortesi I; Panazza S; Crosignani PG
Am J Obstet Gynecol; 1996 Aug; 175(2):396-401. PubMed ID: 8765259
[TBL] [Abstract][Full Text] [Related]
18. Nonbarrier contraceptives and vaginitis and vaginosis.
Roy S
Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1240-4. PubMed ID: 1951581
[TBL] [Abstract][Full Text] [Related]
19. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
20. Neoplasia and dysplasia of the cervix uteri and contraception: a possible protective effect of the diaphragm.
Wright NH; Vessey MP; Kenward B; McPherson K; Doll R
Br J Cancer; 1978 Aug; 38(2):273-9. PubMed ID: 698042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
